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WHITE COAT HYPERTENSION IN THE PRIMARY CARE SETTING
Abstract
BACKGROUND: White coat hypertension (WCH) is described as an anxiety-provoked,
elevated in-office blood pressure reading, combined with a normal blood pressure reading
outside of the clinic setting. This condition is often misdiagnosed as hypertension and can result
in unnecessary antihypertensive treatment. PURPOSE: The purpose of this project was to
determine provider adherence to the 2017 American College of Cardiology/American Heart
Association hypertension guidelines for appropriate diagnosis and treatment of patients with
white coat hypertension. METHODS: A retrospective chart review was performed on 100
randomly selected medical records of patients from an urban primary care practice diagnosed
with an elevated blood pressure from January 1, 2018 to November 30, 2018. The use of blood
pressure logs was evaluated before a diagnosis of hypertension was made. Overall blood pressure
management was also evaluated. RESULTS: In this sample blood pressure logs were requested
50% of the time and 24% were then diagnosed with hypertension. Of the 24% of patients who
were diagnosed with hypertension, no logs were used for the diagnosis. Medication was
prescribed in 13% who had an elevated blood pressure without a diagnosis of hypertension.
Nonpharmacologic management was documented in 56% of the sample. CONCLUSION: In this
study, providers did not consistently adhere to the guideline for prescribing antihypertensive
medication and nonpharmacologic management for elevated blood pressure. Findings did not
indicate that home blood pressure monitoring was used for decision-making related to white coat
hypertension. Home blood pressure monitoring is underutilized, and medications may be
prescribed unnecessarily.
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WHITE COAT HYPERTENSION IN THE PRIMARY CARE SETTING
Evaluation of Provider Use of the 2017 American College of Cardiology/American Heart
Association Guidelines for Diagnosis and Management of White Coat Hypertension
Introduction
White coat hypertension (WCH), also referred to as white coat syndrome, affects
approximately one-third of the adult population (Cobos, Haskard-Zolnierek, & Howard, 2015). It
is best described as an anxiety-provoked, elevated in-office blood pressure reading, combined
with a normal blood pressure reading outside of the clinic setting (Cobos, Haskard-Zolnierek, &
Howard, 2015). When this condition is misdiagnosed as hypertension, it results in subsequent
prescribing of unnecessary antihypertensives (Donofrio Angelucci, 2012; Grossman, 2013). The
use of home blood pressure monitoring (HBPM) to correctly identify WCH can prevent
unnecessary medication prescribing, as well as a foreseeable 14% reduction in medical costs
(Whelton et al., 2017). The purpose of this project was to determine if providers were following
the 2017 American College of Cardiology/American Heart Association (ACC/AHA)
hypertension guidelines, for appropriate diagnosis and treatment of patients with WCH.
Background
WCH is defined as an elevated in-office blood pressure reading that exceeds 130/80 mmHg,
but less than 160/100 mmHg. It is accompanied by ambulatory blood pressure readings of less
than 130/80 mmHg (Whelton, et al., 2017). Approximately 33% of adult patients have WCH
(Cobos, Haskard-Zolnierek, & Howard, 2015). This can result in prescribing unnecessary
antihypertensive medications which can cause hypotension, syncopal episodes, falls, as well as
the risk of medication side effects (Whelton et al., 2017). This condition can be correctly
identified through either ambulatory blood pressure monitoring (ABPM) or HBPM. This can
4
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prevent unnecessary medication prescribing and reduce medical costs by 14%. Not only are costs
to the healthcare system decreased but blood pressure values from the home setting may result in
fewer visits to the provider, a cost savings for those with high deductibles (Wang et al., 2013).
ABPM is defined as an electronic blood pressure monitoring device that the patient wears to
measure blood pressure at designated intervals during daily activities and at rest (CDC, 2017;
Whelton et al., 2017). Home blood pressure monitoring, also known as self-measured blood
pressure monitoring, is defined as a blood pressure reading which is taken at home or elsewhere
outside of the clinic setting. While ABPM is considered the best out of office measurement,
HPBM is a more practical method (CDC, 2017; Whelton et al., 2017). The anticipated success of
HBPM is to capture an accurate blood pressure that is not falsely elevated, and to thus properly
identify normotensive versus hypertensive patients. The benefit of HBPM is that the patient is in
a less tense and more comfortable environment, allowing a more accurate blood pressure reading
to be captured (Donofrio Angelucci, 2012).
The success of home blood pressure monitoring is integral in determining white coat
hypertension. Patients need to be instructed on how and when to record a home blood pressure.
Using the CDC, 2017 recommendations patients should take their blood pressure at the same
time every day with feet flat on the floor. Additionally, the arm should be at heart level with an
adequately sized cuff (CDC, 2017).
Home blood pressure monitoring documented in a patient-kept blood pressure log has
been shown to properly identify white coat syndrome. Readings outside an office setting allow
for a less stressful physiological response (Whelton et al., 2017). Patient-kept blood pressure logs
detailing their home blood pressure readings have also been shown to be a more reliable
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indicator of cardiovascular outcomes (Wang et al., 2013). To date, no other reliable screening
tool exists to accurately identify white coat syndrome (Piper, Evans, Burda, et al., 2014).
For providers, a number of options can be used to document the patients home blood
pressure readings. There is now technology available for providers to upload patients home
blood pressure logs into an electronic health record for their review. If this is not available,
providers can simply document a patient’s home blood pressures in a communication encounter
via an email, telephone call, or through the electronic health record.
Purpose and Objectives
The purpose of this project was to determine if providers were following the 2017 ACC/AHA
hypertension guidelines, for appropriate diagnosis and treatment of patients with WCH. More
specifically, this project aimed to determine the percentage of:
1. Patients with an elevated blood pressure diagnosis that were instructed to complete a
home blood pressure log documented in the electronic health record,
2. Patients with an elevated blood pressure diagnosis who had completed home blood
pressure logs on a subsequent encounter
3. Primary care providers who used home blood pressure logs for prescribing an
antihypertensive, and
4. Providers who followed the 2017 ACC/AHA guidelines for the appropriate diagnosis and
management of hypertension.
Methods
The setting of this project was in a large Kentucky urban healthcare organization where
there are multiple primary care practices. The population that is served within the primary care
6
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clinics is across the lifespan with varying disease processes and diagnoses. For this project, only
adults were included and subsequently receiving care at any one of the primary care practices. A
retrospective design was used to determine provider adherence to the ACC/AHA 2017
hypertension guidelines for appropriate diagnosis and treatment of patients with WCH.
Sample
The inclusion criteria for the sample were: 1) all patients over the age of 18 years, 2)
established patients in one of the primary care clinics, 3) a blood pressure reading greater than or
equal to 130/80, 4) a diagnosis of an elevated blood pressure reading without a diagnosis of
hypertension, and 5) an encounter in one of the clinics between January 1, 2018 and November
30, 2018. The ICD-10 diagnostic code for an elevated blood pressure without a diagnosis of
hypertension is R03 and was used as a proxy for a diagnosis of WCH. Exclusion criteria for the
sample consisted of an existing hypertension diagnosis, not seen within the past 6 months at the
primary care clinic, presence of chronic kidney disease, and presence of congestive heart failure.
A total of 51,000 patients were identified from the healthcare system as having any
diagnosis of elevated blood pressures which included hypertension. From that list, 100 charts
were randomly selected that met the inclusion criteria with the diagnostic code of R03. Charts
were reviewed for the following: a) documentation in the plan that the provider requested the
patient keep a blood pressure log, b) documentation that a patient-kept home blood pressure log
was kept, c) documentation that the log was used in a subsequent visit to determine hypertension,
d) documentation of pharmacological and nonpharmacological measures per the 2017
ACC/AHA guidelines. Data were also collected on demographics of age, gender and race.
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Informed Consent
A waiver of informed consent was requested from the University of Kentucky Institutional
Review Board as there was minimal risk and no direct contact with patients. The waiver was
approved by the University of Kentucky Institutional Review Board. The evaluation was
reviewed and approved by the healthcare organization’s office of research.
Procedures
The healthcare organization’s information technology department assisted in retrieval of
electronic health records from the EPIC electronic health record software. The first encounter
where the diagnosis of elevated blood pressure without a diagnosis of hypertension was the
starting point for the chart review. One subsequent visit was then explored to evaluate how blood
pressure logs were used to diagnose hypertension. If there was no subsequent visit the chart was
examined for follow-up of those who were instructed to keep a blood pressure log. The collected
data was stored on a secure and encrypted H drive. The computer storing the collected data was
password protected, which ensured patient confidentiality.
Data Analysis
Descriptive statistics were used to describe the demographics of the sample. Frequencies
were used to determine whether 1) there was documentation in the plan that a blood pressure log
had been requested, 2) a blood pressure log was uploaded in the electronic health record, 3) a
diagnosis of hypertension was documented at a subsequent visit 4) a follow-up blood pressure
reading occurred after the initial elevated blood pressure encounter and 5) an antihypertensive
medication was prescribed for patients with a diagnosis of elevated blood pressure without a
diagnosis of hypertension, (R03).
8
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Results
A total of 100 medical records were randomly selected from a total of 51,000 patients
with either a diagnosis of hypertension or an elevated blood pressure without a diagnosis of
hypertension. The majority of patients in the sample were female (53%) and 84% were over the
age of 35. Those aged 55 or older encompassed 24% of the sample. Over half were Caucasian
(58%) and almost a fourth (24%) were African American (see Table1).
The diagnosis of an elevated blood pressure without a diagnosis of hypertension was
recorded in 76% of the sample and 24% were diagnosed with hypertension at the initial visit.
Providers documented that a blood pressure log was requested in 55% of those who had a
diagnosis of an elevated blood pressure without a diagnosis of hypertension. Since 24% were
seen later in the chart review time frame, no subsequent visits were evaluated for those patients.
A few patients (3%) did not keep their follow-up appointment. Among those who had a
subsequent visit (73%) and were instructed to keep the log, only one-third had documentation of
HBPM log in the EHR.
At the initial visit, blood pressure medication was prescribed for 3% of those with an
elevated blood pressure who had a reading greater than 160/100 mmHg. Antihypertensive
medication was prescribed to 10% who were diagnosed with an elevated blood pressure without
a diagnosis of hypertension (R03) at the initial visit. Their blood pressure readings were greater
than 130/80 but less than 160/100 mmHg. Those who had a subsequent visit (n=73), 61% did not
have an elevated blood pressure above 130/80 mmHg from either the blood pressure log or the
in-office reading. The HBPM confirmed a normal pressure for 88% of those who kept the log.
Those who were assigned a diagnosis of hypertension (24%), versus an elevated blood
pressure reading without a diagnosis of hypertension, all had a follow-up appointment within the
9
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study period. There were no requests for HBPM within this group. Approximately half were
prescribed (n=10) an antihypertensive medication despite blood pressures that were less than
160/100. The remaining patients (n=14) who were given the diagnosis of hypertension were
instructed by the provider to implement nonpharmacological interventions as an attempt to lower
blood pressure.
Nonpharmacologic management for blood pressure was documented at the first visit for
approximately 65% of the total sample. The most common recommendations were for weight
loss, adhering to the DASH diet, increasing physical activity, and decreasing or stopping alcohol
intake. This was documented through the use of an electronic handout that is printed out and
given upon discharge of the patient.
Discussion
A retrospective chart review was performed to determine provider adherence to the 2017
ACC/AHA hypertension guidelines for appropriate diagnosis and treatment of patients with
WCH. WCH is a common problem amongst those in the middle age group which was reflected
in the sample. The frequency of WCH hypertension increases with age and is most common in
middle-aged and older adults.(Cobos, Haskard-Zolnierek, & Howard, 2015). In this sample
group ethnicity was not reflective of the epidemiology of the disease, however there was no
attempt to compare ethnic groups. Aronow et al, (2019) described the demographic findings of
the Dallas Study as such: 63% of the WCH population and 69% of the hypertension population
were black.
In this project, providers adhered to the guideline in over half of the patients initially
seen with an elevated blood pressure. Though HBPM readings were not uniformly requested by
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the providers the majority (73%) had a follow-up appointment and were treated appropriately
according to the guideline recommendations based upon either the blood pressure log or the inoffice reading. Blood pressure logs, when used, did confirm WCH. These findings are similar to
Burnier and Eganfrom (2019) who found hypertension and WCH was treated appropriately 70%
of the time.
It is unclear why blood pressure logs were not requested by the providers. Reasons
identified in the literature for not using HBPM include concern about the accuracy of the blood
pressure measurement, as well as the cost incurred to the patient (George, & McDonald, 2015)
Yet Whelton et al. (2017) state that the HBPM reading mirrors the in-office reading and
insurance companies will pay for a cuff. In addition, there are readily available community
resources were blood pressures can be obtained such as pharmacies, and fire stations. Further,
providers may be hesitant as they feel it will be an additional burden placed on the patient or they
don’t feel that patients will comply.
Nonpharmacologic interventions are supported by the guideline. The ACC/AHA
guideline recommends a three-month trial of lifestyle modification and ABPM or HBPM with
follow-up before prescribing medications (Whelton et al., 2017). In two-thirds of the sample the
providers did document lifestyle interventions to control blood pressure. Support from the EHR
that details lifestyle behaviors that contribute to hypertension is readily available. Though the
EHR provides access to patient education, it is unclear whether the education is patient specific,
or the amount of attention and emphasis is placed on lifestyle. This may explain in part why onethird of the providers did not include patient education. The other consideration is that it was
discussed but not documented.
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Providers often underutilized the many capabilities imbedded within the EHR. For
example, the system may offer an alert that the blood pressure reading is elevated and link the
provider to the appropriate management guideline. The EHR could also be used to alert staff for
follow-up on those patients requested to complete HBPM. In this project, one-third of the
patients who were instructed to complete HBPM did not have follow-up documentation of its
completion. This could have been just a documentation issue. Liability for lack of follow-up on
an elevated blood pressure reading cannot be minimized. Patient’s may be unsure of what all
HBPM entails and the provider is responsible for providing the necessary information from a
liability standpoint (Shore, 2007).
Limitations
There are several limitations noted in this project. The sample size was small and without
meaningful diversity. An additional limitation is that the RO3 proxy code was not uniformly
utilized and therefore patients were missed who could have met the inclusion criteria. Neither
providers’ nor patients’ input was solicited. They could have provided insight on the burden of
completing HBPM. Since 24 patients were seen later in the chart review time frame, no
subsequent visits were evaluated. In addition, the guidelines being relatively new may not have
been adopted by the providers which would have been forthcoming in a provider interview.
Implications for Practice
The use of electronic health record alerts can improve adherence to guidelines (Sroujieh,
Monroy, & Warren, 2016). An alert can serve as a prompt to the provider regarding new
evidence-based guidelines such as ordering ABPM or HBPM. The EHR could also be used to

12

WHITE COAT HYPERTENSION IN THE PRIMARY CARE SETTING
improve communication with patients to remind or follow-up on the for HBPM. Providers need
continuous in-services on the EMR capabilities, including how to upload a patient log.
Providers may find patients are unaware of community resources for blood pressure
readings. A simple list could be constructed and given to the patient detailing where community
blood pressures are available. For those who have a home blood pressure cuff, it would be
helpful if patients brought the HBPM device and their readings to the office for verification of
their technique.
Finally, most important, providers need to be made aware of the 2017 guidelines with
appropriate follow-up on their adherence. The role of the medical assistant could be used to
assist providers in identifying WCH. It would be helpful to standardize how patients are being
roomed with a trigger to repeat blood pressures if they are elevated.
Implications for education and further study
It would be important to do a needs assessment to determine provider knowledge of the
2017 ACC/AHA blood pressure guidelines with a larger sample size. If providers are not aware
of the revisions regarding WCH treatment, this could be an opportunity to provide education on
the details of the guidelines. Patients also need education on the new recommendations for blood
pressure management. Many may still think that a reading of 140/90 mmHg is the treatment
goal, which does not match that of the 2017 guidelines.
Conclusion
In this study, providers did not consistently adhere to the 2017 ACC/AHA guideline for
the diagnosis and treatment of WCH. Findings did not indicate that home blood pressure
monitoring was used for decision-making related to white coat hypertension. In today’s
13
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healthcare environment every opportunity must be made to encourage patient’s involvement in
their overall health. Encouraging patients to monitor their home blood pressure may engage them
in taking an active role. Providers should stay apprised of ACC/AHA guidelines and use EHR’s
to their full potential in order to provide appropriate management of WCH.

14

WHITE COAT HYPERTENSION IN THE PRIMARY CARE SETTING
References
Aronow, W., S., et al. (2019). Emergence of home blood-pressure-guided management of
hypertension based on global evidence. Hypertension, 74:229-236.
Abir-Khalil, S., Zaimi, S., Tazi, M., Bendahamane, S., Bensaoud, O., & Benomar, M. (2009).
Prevalence and predictors of white-coat hypertension in a large database of
ambulatory blood pressure monitoring. East Mediterranean Health Journal, 15(2), 40008.
American Heart Association/American College of Cardiology. (2017). Blood pressure
guidelines. Retrieved from https://www.acc.org.
Banegas J.R, Ruilope L.M., de la Sierra A, et al. (2014). High prevalence of masked
uncontrolled hypertension in people with treated hypertension. European Heart Journal,
35:3304–12.
Burnier, M., & Eganfrom, B. M. (2019). Adherence in hypertension A review for prevalence,
risk

factors, impact and management. Circulation Research. 124:1124-1140.

Centers for Disease Control and Prevention. (2017). Self-measured blood pressure monitoring
with clinical support. Retrieved from https://www.cdc.gov/dhdsp/pubs/guides/bestpractices/smbp.htm.
Cobos, B., Haskard-Zolnierek, K., & Howard, K. (2015). White coat hypertension: improving
the patient-health care practitioner relationship. Psychology Research and Behavior
Management. 8:133-41.
15

WHITE COAT HYPERTENSION IN THE PRIMARY CARE SETTING
Cohen, J. B., Lotito, M. J., Trivedi, U. K., Denker, M. G., Cohen, D. L., & Townsend, R. R.
(2019). Cardiovascular events and mortality in white coat hypertension: A systematic
review and meta-analysis. Annals of Internal Medicine. Retrieved from
https://annals.org/aim/article-abstract/2735719/cardiovascular-events-mortality-whitecoat-hypertension-systematic-review-meta-analysis
Donofrio Angelucci, D. (October 2012). White coat hypertension presents an elusive challenge.
Hypertension. Retrieved from https://acpinternist.org.
George, J., & MacDonald, T. (2015). Home blood pressure monitoring. European Cardiology
Review. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159400/
Grossman, E. (2013). Ambulatory blood pressure monitoring in the diagnosis and management
of hypertension. Diabetes Care. Retrieved from
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920799/
Krakoff, L. R. (2006). Cost effectiveness of ambulatory blood pressure-A reanalysis.
Hypertension. 47(1): 29-34.
Piper, M. A., Evans, C. V., Burda, B. U., et al. (2014). Screening for high blood pressure in
adults: A systematic evidence review for the U. S. preventative services task force.
Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK269501/
Shore, K. (2007, December 21). When Patients skip the follow-up. Retrieved from
https://www.medicaleconomics.com/modern-medicine-feature-articles/when-patientsskip-follow

16

WHITE COAT HYPERTENSION IN THE PRIMARY CARE SETTING
Wang, C. Y., Koval, A. M., Nakamura, M., Newman, J. D., Schwartz, J. E., & Stone, P. W.
(2013). Cost-effectiveness of secondary screening modalities for hypertension. Blood
Pressure Monitoring, 18(1), 1-7.
Whelton, P.K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., . . . Wright, J. T.
(2017). Acc/aha/aapa/abc/acpm/ags/apha/ash/aspc/nma/pcna Guideline for the
Prevention, detection, evaluation, and management of high blood pressure in adults:
A report of the American College of Cardiology/American Heart Association task force
on clinical practice guidelines. Hypertension 71(6), 1-398.

17

WHITE COAT HYPERTENSION IN THE PRIMARY CARE SETTING
Table 1. Demographics (N=100)
Demographics

Gender
Male
Female
Age
18-24
25-34
35-44
45-54
55-65
>65
Race
American Indian
Asian
Black
Hispanic
White

Frequency

Percentage

47
53

47%
53%

6
10
13
15
24
32

6%
10%
13%
15%
24%
32%

1
6
24
11
58

1%
6%
24%
11%
58%

Table 2. Visit characteristics following initial elevated BP reading encounter (N =100 )
Characteristics
Frequency
Percentage
Blood pressure log requested
Yes
55
55%
No
45
45%
Blood pressure log uploaded
Yes
34
34%
No
66
66%
Follow-up blood pressure
reading
Yes
No
Hypertension Diagnosis
Yes
No
Medication Prescribed
Yes
No
Guidelines Adherence
Yes
No

55
45

55%
45%

24
76

24%
76%

13
87

13%
87%

58
42

58%
42%
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